Hikma Pharmaceutical | HIK - Market Capitalization

Stock Price
1,653.00
Daily Change
34.00 2.10%
Monthly
5.42%
Yearly
-28.01%
Q1 Forecast
1,600.34

Hikma Pharmaceutical reported $3.66B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Almirall EUR 2.75B 8.36M Feb/2026
argenx SE USD 44.32B 15.63B Sep/2025
AstraZeneca USD 222.33B 65.82B Feb/2026
Autolus Therapeutics Ltd USD 433.81M 172.99M Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
Fresenius EUR 26.7B 2.66B Sep/2025
Galapagos EUR 1.93B 10.54M Feb/2026
Genmab DKK 80.88B 7.82B Jun/2025
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
GRIFOLS EUR 7.49B 1.16B Sep/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Orion EUR 7.27B 1.67B Feb/2026
Recordati EUR 9.81B 343.76M Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025